Design and interpretation of experiments to establish enzyme pathway and define the role of conformational changes in enzyme specificity
Methods in Enzymology · 2023 · 461-492
DOI: 10.1016/bs.mie.2023.03.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2023. Verfasst von Tyler L Dangerfield und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, United States. Hauptthemen laut MEDLINE: DNA-Directed DNA Polymerase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, United States.
- Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, United States. Electronic address: kajohnson@utexas.edu.
Förderung
- NIAID NIH HHS
- NIBIB NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- Intel Corporation
- National Institutes of Health
Zitieren
APA
Dangerfield, T. L., & Johnson, K. A. (2023). Design and interpretation of experiments to establish enzyme pathway and define the role of conformational changes in enzyme specificity. Methods in Enzymology, 461-492. https://doi.org/10.1016/bs.mie.2023.03.018
Vancouver
Dangerfield TL, Johnson KA. Design and interpretation of experiments to establish enzyme pathway and define the role of conformational changes in enzyme specificity. Methods in Enzymology. 2023:461-492. doi:10.1016/bs.mie.2023.03.018
BibTeX
@article{Dangerfield2023,
author = {Dangerfield, Tyler L and Johnson, Kenneth A},
title = {Design and interpretation of experiments to establish enzyme pathway and define the role of conformational changes in enzyme specificity},
journal = {Methods in Enzymology},
year = {2023},
pages = {461--492},
doi = {10.1016/bs.mie.2023.03.018}
}
EUVIMED